In late December, as the omicron variant surged, the roster of early Covid-19 treatments was looking slim. Newly authorized pills for Covid-19 were in short supply. Several monoclonal antibody drugs ...
FOSTER CITY, Calif., September 29, 2022 /CSRwire/ - Gilead Sciences, Inc. (Nasdaq: GILD) today announced updates to the World Health Organization’s (WHO) Therapeutics and COVID-19: living guideline, ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The combination treatment reduced the need for ...
The majority of people who contract COVID-19 don't need to seek treatment and can typically battle the infection on their own, but that's not always the case, and there are various treatments ...
Excitement is building over remdesivir as a treatment for COVID-19. On Friday, the Food and Drug Administration authorized the emergency use of remdesivir to treat COVID-19, President Trump announced.
Veklury (remdesivir) is a nucleotide analog invented by Gilead, building on more than a decade of the company’s antiviral research. Veklury is the antiviral standard of care for the treatment of ...
At least two Midlands hospitals are involved in efforts to test a drug that health officials hope could treat the COVID-19 virus and weaken its effects on the body. Prisma Health and Lexington Medical ...
The US Food and Drug Administration announced Monday that it has expanded approval of the Covid-19 drug remdesivir to treat patients as young as 28 days and weighing about 7 pounds. This is the first ...
The majority of people who contract COVID-19 don't need to seek treatment and can typically battle the infection on their own. That's not always the case, however, especially for those who are high ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback